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Director’s introduction
Martin Knapp
There is today, as there has always been, an important
‘economic agenda’ running through mental health
policy. This agenda has both macro and micro aspects:
that is, questions are raised both about the operation of
the whole mental health care system and about the
efficiency and equity of specific care and treatment
arrangements within it.
This is also the agenda for the PSSRU’s Mental Health
Economics and Policy Programme, at the LSE and the
University of Kent, and for the work of the Centre for the
Economics of Mental Health, at the Institute of
Psychiatry.
Since the PSSRU first started to conduct research on
mental health care (and care for people with learning
disabilities) in the mid 1980s, and particularly since the
formal establishment of a programme in 1991, our
research activities have drawn from across this agenda
and have been heavily influenced by the developing
policy and practice contexts in England. When CEMH
was established in 1993 in London, we had the further
opportunity to examine both macro and micro issues in
relation to both policy and practice. A very busy work
schedule in the intervening six years has contained a
great many macro and micro studies.
Much of the research conducted within PSSRU and
CEMH has been genuinely inter-disciplinary, as will be
clear from this and previous issues of the Mental Health
Research Review. Of course, running strongly through
most of the work has been the use of economic
concepts, methods and techniques. This bias towards
economics has not been because we believe this
particular disciplinary perspective to be inherently
superior to others. Nor in fact is it simply because
many members of the two groups are economists.
The primary reason has been that economic
questions are frequently being posed but only rarely
being answered. There are still surprisingly few
researchers interested in addressing the various
economic questions raised by numerous and pressing
practice and policy developments in the mental health
sphere.
A core objective of the programmes at PSSRU and
CEMH has been to disseminate the findings of our
research widely and in accessible forms. Pages 41-42
of this Review give brief details of many articles,
books and book chapters published since last year’s
issue.
The Mental Health Research Review itself is also an
important dissemination vehicle (as the complete
contents list for previous five annual issues, which
appears on the inside back cover, suggests). This
sixth issue — expertly edited by Daniel Chisholm and
Stephen Almond — describes much of the recent and
current mental health research by PSSRU and CEMH.
There is only space for summary accounts of some of
our work, so please contact us if you would like to
know more.Mental Health Research Review 6, May 1999 3
Editors’ introduction
Daniel Chisholm and Stephen Almond
The merit of a health economics study in terms of
coverage and generalisability is determined to a
significant extent by three parameters (see table 1):
 As in clinical evaluation, an important consideration
for the review, assessment and interpretation of
economic evidence is research study design.F o r
example, is the economic study part of a
prospective, controlled trial, a retrospective study
with no control group, or based on secondary data
sources?
 A further feature relates to the type of economic
evaluation, which is focused on the way in which
outcomes are measured and compared with costs.
 A final characteristic is the scope or perspective of
the study, which is concerned with the extent to
which the costs and consequences of an
intervention across all relevant parties have been
assessed.
Viewed as an inter-connected hierarchy, the most
robust form of evidence upon which to base decisions
on cost-effectiveness and resource allocation is one
conducted prospectively with two (or more)
appropriately-sized, randomly-allocated groups of
patients, for whom all conceivable costs and outcomes
are measured in a common currency. Owing to the
difficulty in quantifying all outcomes in monetary terms,
most studies to date have in fact been
cost-effectiveness or cost-consequences analyses,
based on a range of clinical measures and often
employing the cost perspective of the formal service
sectors only. For example, the two research studies
described by Daniel Chisholm and colleagues in this
year’s edition of the Mental Health Research Review
are instances where an observational design has been
employed to assess changes in (a wide range of)
costs and outcomes over a brief follow-up period. By
contrast, Judy Clegg and Juliet Henderson provide
early results of a longitudinal cohort study of boys with
developmental language disorders in which lifetime
costs across the domains of education,
accommodation, health and employment are
estimated. Other examples of ongoing or recently
completed cost-outcome studies, using a range of
study designs and perspectives, are also summarised.
Cost studies carried out in isolation from collection of
data on user outcomes can also contribute
significantly to our understanding of the economic
impact of a disorder or to the improved planning of
services: Jennifer Beecham provides an up-to-date
picture of the providers and users of day activity
settings for people with mental health problems,
together with an analysis of components of support
and their associated costs.
Where prospectively collected data are unavailable,
resource utilisation, cost and outcome data can be
obtained from secondary sources in order to simulate
the expected effects of a new mental health care
intervention or strategy. Stephen Almond tackles a
number of unresolved issues in simulation modelling
of schizophrenia, whilst Paul McCrone, Daniel
Chisholm and Carla Croft. describe an attempt to
place costs on a range of alternative service models.
Most removed from primary research, but no less
informative, are meta-analyses and systematic or
expert reviews. Martin Knapp provides a review of the
cost-effectiveness evidence relating to schizophrenia
that has been generated by CEMH, PSSRU and other
research teams.
Table 1 Parameters determining the coverage of health economics studies
Parameter 1
Study design
(What ratings are based on)
Parameter 2
Costing scope/perspective
(What costs are included)
Parameter 3
Type of economic evaluation
(How costs and outcomes are
combined)
Non-empirical
(e.g. administrative database)
Single care agency
(e.g. health service only)
Cost-minimisation analysis (CMA)
(outcomes are the same)
Observational
(e.g. cross-sectional study)
All formal care agencies
(e.g. voluntary sector included)
Cost-effectiveness analysis (CEA)
and cost-consequences analysis
(e.g. cost per change in depression)
Quasi-experimental
(e.g. retrospective study)
Formal & informal care agencies
(e.g. lost employment included)
Cost-utility analysis (CUA)
(e.g. quality adjusted life year)
Experimental
(e.g. RCT)
All societal costs
(e.g. user/carer distress included)
Cost-benefit analysis (CBA)
(all costs and outcomes monetised)Schizophrenia: improving cost-effectiveness
Martin Knapp
Introduction: the high costs of schizophrenia
The direct health and social care costs for supporting people with schizophrenia
in England in 1992/93 amounted to £810 million, and the overall cost of illness
was approximately £2.6 billion, even without including caregiver costs (Knapp,
1997). These high costs are recurrent: schizophrenia is an early-onset, chronic,
incurable illness which can severely damage the quality of life of sufferers and
families. It also raises societal concerns, for example about personal and public
safety.
It is not surprising, therefore, that a lot of policy and practice attention has been
given to the support and treatment of people with schizophrenia. There are, for
example, concerns about the heavy demands on in-patient services: more than
5% of NHS expenditure on in-patient beds was accounted for by schizophrenia
patients in 1992/93, and while this proportion will have fallen over recent years, it
remains the case that this low-prevalence illness is a major reason for
hospitalisation.
Other concerns have been voiced about the organisation of effective community
care, about public safety and about the inappropriateness of currently available
care regimes for some patient groups (particularly black and ethnic minority
groups). Much interest has been expressed in the atypical antipsychotic drugs
recently launched onto world markets, and in using psychosocial treatments such
as cognitive behavioural therapy.
Evidence has been accumulating for a few years on the economic impact of a
number of different care arrangements and treatment modalities for people with
schizophrenia. PSSRU and CEMH studies in this field are making contributions
to this growing evidence base. The purpose of this paper is to summarise findings
from PSSRU and CEMH studies and outline the aims of some studies which
have recently begun. A substantial review chapter has also recently been
completed (Knapp, Almond and Percudani, 1999).
The UK policy context
A good starting point for understanding the UK policy context — which
influences the orientation of much of our work — is the 1990 National Health
Service and Community Care Act. The Act had a number of well-known
intentions and consequences. Four particular features of the Act have especial
pertinence for mental health. The first was to move away from decision-making
dominated by the availability of services to a system which sought to tailor service
responses to the individual needs and preferences of users and their families. A
second key element was the development of a more mixed economy of care,
rather than health and social care systems being dominated by the public sector.
Third, there was some rebalancing of the relative responsibilities of the NHS and
local authority social services departments. Fourth, there was considerable
emphasis on community-based care as an alternative to institutional provision,
continuing what was in fact a long-term trend in the UK.
Subsequent to the 1990 Act a number of specific initiatives were launched,
particularly the Care Programme Approach introduced in 1991, the Mental
Illness Specific Grant to channel money to social services departments, the
promotion of supervision registers and the introduction of supervised discharge
arrangements. These were all built onto the basic architecture of the 1990 Act,
4 Mental Health Research Review 6, May 1999and have exerted greater or lesser influences on local mental health care
arrangements subsequently.
Since its election in 1997, the Labour Government has clearly given health policy
some priority. In many respects the policy emphases are not so very different
from those of the Conservatives, despite the obvious desire of ministers to
distance themselves from what has been achieved — or not — over recent years.
For example, there continues to be considerable reliance placed on
community-based options for people with mental health problems, although the
new Government has been quick to stress that these must be ‘safe, sound and
supportive’. It has been more explicit in promising additional resources to allow
the development of 24-hour nurse-staffed hostels, assertive outreach teams and a
number of other service components. There is greater emphasis on the
(evidence-based) promotion of quality and user outcomes. Precise details of the
new policy are eagerly awaited.
Improving cost-effectiveness?
Given the high costs of schizophrenia, there is understandable pressure to
contain expenditure whilst nevertheless improving outcomes. In other words,
cost-effectiveness improvements are being sought. Some particular
policy/practice themes have been examined in PSSRU/CEMH research, each
looking at ways of improving cost-effectiveness:
 medication compliance
 drug treatments
 community reprovision from long-stay hospital
 community diversion (including assertive outreach)
Figure 1 gives a schematic representation of a set of hypotheses which evaluative
research on the treatment of schizophrenia should be addressing. It makes the
links between treatment or care arrangements on the left-hand side, through two
very important intermediate effects (side-effects and compliance), and so on to
the outcomes which might be attained. Success in achieving some of these
outcomes should have longer-run effects on the costs of the care system and the
costs to other stakeholders (including people with schizophrenia themselves and
their families).
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Treatments
Antipsychotic
medications
Psychological
interventions
Other
treatments
Intermediate
effects
Outcomes
… health care utilisation
… social support
… employment
… integration
… carer employment
… compliance
… externalities
Functioning …
Access to resources …
Quality of life …
Caregiver burden …
Satisfaction with treatment …
Symptoms …
Societal outcomes …
Longer-term costs
Side
effects
Compliance
Figure 1 Treatments for schizophreniaCompliance therapy One particular concern in schizophrenia treatment is the
high rate of relapse: many people with schizophrenia experience repeated acute
episodes of the illness. There are good personal, clinical and economic reasons
for wanting to prevent relapse or lessen its impact. The economic concerns are
arguably the least important but certainly not irrelevant.
A meta analysis of trial-based evidence by Weiden and Olfson (1995) concluded
that the costs of in-patient hospitalisation for first-episode cases amounted to
about $2.3 billion annually in the USA. Relapses over the subsequent two years
cost in the region of $2 billion. They estimated that roughly two-thirds of the
costs of schizophrenia relapse could be attributed to loss of medication efficacy
and one-third to medication non-compliance. Not surprisingly, therefore, care
professionals have tried to improve users’ agreement with and adherence to their
treatment programmes.
Roisin Kemp, Anthony David and colleagues at the Maudsley Hospital have
developed and evaluated a short counselling intervention, which they call
compliance therapy, which targets this particular problem. People awaiting
discharge from in-patient care are invited to discuss first their attitude towards
their illness, and subsequently the drawbacks and advantages of drug treatment.
A randomised controlled trial found that people with psychoses counselled in this
way were five times more likely than a control group receiving non-directional
counselling to take their medication without prompting. Over an 18-month
follow-up period they had better global functioning, insight, compliance and
attitudes to their medication (Kemp, Kirov, Everitt and David, 1998).
The economic component of this trial, carried out by CEMH, found that costs
were no more than with standard counselling (Healey et al., 1998). The
economic analysis covered all health and social care services, education, social
security and housing supports, and criminal justice contacts, but excluded
caregiver and lost employment costs. The evaluation found costs to be the same
for compliance therapy as for standard counselling during each of the three
six-month follow-up phases and over the full 18 months. Costs were higher for
patients with greater symptomatology. Significant correlations were found
between greater compliance and higher costs over the first six months. That is,
improving compliance will initially increase costs, although over time there is an
offsetting reduction. ‘Compliance therapy’ appears to be an efficient intervention.
Drug treatments A psychopharmacological revolution in schizophrenia is
underway, although at different rates in different countries. The so-called atypical
(novel) antipsychotics are being heralded as drugs which may be able to improve
the impact on symptoms over conventional medications, although there is
inevitably dispute over just how marked these effects might be. There is less
dispute that the atypical drugs have fewer adverse side-effects. Conventional
antipsychotics are disliked by many patients because of their side-effect profiles.
The growing body of economic evidence on the atypicals has not yet been
subjected to formal systematic review. Much of it is very recent. What the
evidence appears to suggest, however, is that the atypical antipsychotics have the
ability to reduce the need for in-patient hospitalisation, and also to reduce the
demands on other service providers in the community. The new drugs look like
cost-effective alternatives to the conventional antipsychotics, and in conjunction
with psychosocial therapies may eventually prove to be very effective. Evidence
for this comparative cost-effectiveness comes from a number of sources,
including simulations (decision modelling), retrospective analyses of ‘naturalistic’
databases, and prospective trials.
The PSSRU/CEMH group is actively participating in studies of each of these
kinds of analysis. There are three prospective, randomised controlled trials, two
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atypical drug and the other looking at all atypicals as a class. The general
randomised trial, called CUtLASS, is a multi-centre (UK), multi-disciplinary
study funded under the NHS Health Technology Assessment programme. It is
led by Professor Shôn Lewis (Manchester) and involves researchers from
Manchester, York, Nottingham, Imperial College London and the Institute of
Psychiatry.
A number of simulation studies have been conducted by Stephen Almond
(PSSRU). One of these is a five-year, Markov process model of transitions
between health states (over three-monthly cycles) comparing olanzapine and
haloperidol (Almond and O’Donnell, 1998). Key clinical pathways included
positive and negative symptoms, relapse, dropping out and switching therapy.
The study found similar costs for the projected paths of the two drugs.
Community reprovision A long-running theme of research at PSSRU has
been the impact of moving long-stay hospital residents to live in the community.
Internationally, probably the most comprehensive and longest running evaluation
of community-based care for former long-stay in-patients has looked at the
closure of Friern and Claybury hospitals in North London. The former residents
of these two hospitals were studied for five years after their discharge from
hospital. Evidence was collected on their quality of life, health status,
accommodation, service use patterns and costs.
The project was led by Julian Leff (Institute of Psychiatry). His team found that
former in-patients were enjoying a quality of life at least as good as in hospital
(Leff, 1997). There were no problems with higher-than-normal mortality,
homelessness or crime. Accommodation stability in the community was good,
and care environments were rated as better than hospital. Social networks were
stable — a minority gained in this respect, but most were not socially integrated
into local communities. Hospital readmissions were quite common (38% of the
sample had at least one readmission over a five-year period). Psychiatric
symptoms and social behaviour were very stable over time. Importantly, users
clearly preferred community living to hospital.
The associated economic evaluation was carried out by Jennifer Beecham, Angela
Hallam and Martin Knapp. We found that many services were used in the
community, provided by a range of health, social care and other agencies. The
one-year results are described by Beecham et al. (1997). Patterns of service use
had changed somewhat over the five-year follow-up period. However, when
summed together, the costs of these services were no different from the costs of
the long-stay hospital care which people left. Consequently, the weight of the cost
and outcome findings suggested that community care was more cost-effective
than hospital care. Higher cost community care packages appear to be associated
with better individual outcomes.
A supplementary investigation used the data after one year in the community to
see if there were outcome, quality of care or cost differences between community
provision in the public sector (separating NHS from local authority provision),
voluntary (non-profit) sector and private (for-profit) sector. There were also a
number of NHS-voluntary consortia accommodating former hospital residents.
We found some significant cost and quality of care differences between the
provider sectors, and a few outcome differences. Generally, care appeared to be
more cost-effective in the public than in the private sectors (Knapp, Hallam,
Beecham and Baines, 1999s).
Community diversion (assertive outreach) Much professional and policy
attention has focused on the assertive community treatment (ACT) or outreach
model developed in Madison, Wisconsin. There are, of course, many different
Mental Health Research Review 6, May 1999 7arrangements now in place to coordinate community care for people with acute
mental health problems, but the different variants of ACT have generated special
interest because of their apparent abilities to improve outcomes while containing
or reducing costs (Weisbrod, Stein and Test, 1980; Essock, Frisman and Kontos,
1998).
The Daily Living Programme (DLP) was a UK adaptation of the Madison
model, offering intensive home-based care for seriously mentally ill people facing
crisis admission to the Maudsley Hospital. The DLP was set up and evaluated by
Isaac Marks and colleagues, with the associated cost-effectiveness analysis
(actually a ‘cost-consequences analysis’ in current terminology) being carried out
by PSSRU/CEMH.
A randomised controlled study examined the cost-effectiveness of the DLP
compared to standard in/out-patient hospital care over 20 months, followed by a
randomised controlled withdrawal of half the DLP patients into standard care.
Three patient groups were therefore compared over 45 months, depending on the
support they received: DLP throughout the period, DLP for 20 months followed
by standard care, and standard care throughout. The economic evaluation found
the DLP to be more cost-effective than standard care over months 1-20, and also
over the full 45 month period, but the difference between groups may have
disappeared by the fourth year after initial randomisation (Knapp et al., 1998).
The reduction of the cost-effectiveness advantage for home-based care was
perhaps partly due to the attenuation of DLP care, particularly the loss of
responsibility by the DLP team for in-patient admissions and discharges.
Conclusions
Schizophrenia is a costly illness, not just for the NHS and other public sector
bodies, but for sufferers, their families and the wider society. With the policy
emphasis on community-based mental health care, purchasers, providers and
politicians are urgently searching for more cost-effective modes of support and
treatment.
The research community has responded with a small but rapidly growing number
of economic evaluations of treatment modes and care approaches. Based on the
accumulated evidence, including the PSSRU/CEMH research summarised here,
it seems that cost-effectiveness improvements can be attained in areas of
schizophrenia care. Three of these areas relate to the individual treatment of
schizophrenia patients, through pharmacological or psychological methods.
These treatments can not only be effective in terms of their impacts on symptoms
and patient quality of life, but also cost-effective in making better use of scarce
public sector and other resources.
There is also encouraging evidence in relation to community care for people
either with chronic mental health problems or experiencing acute phases of their
illness. Closing long-stay psychiatric hospital beds has been an occasionally
controversial policy, but one that could pay dividends for the people affected and
for public budgets. Closing acute beds, on the other hand, would presently be a
mistake in some parts of the country, as the services and other supports needed
by people with mental health problems are simply not in place. Nevertheless, the
evidence on assertive outreach, for example in the form of the Daily Living
Programme tried at the Maudsley Hospital, shows that models of care can be
developed that are effective and cost-effective compared to standard
(hospital-centered) arrangements.
Schizophrenia care remains a priority topic for PSSRU/CEMH evaluative
research. Findings from our ongoing programme of studies will be available over
8 Mental Health Research Review 6, May 1999the coming months and years, and will be reported in future issues of this Review
as well as through the usual dissemination channels.
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Key points
 Schizophrenia is a costly illness, not just for the NHS and other public
sector bodies, but for sufferers, their families and the wider society.
 Treatments at the level of individuals can not only be effective in terms of
their impacts on symptoms and patient quality of life, but also
cost-effective in making better use of scarce public sector and other
resources.
 In relation to community care, evidence on assertive outreach shows that
models of care can be developed that are effective and cost-effective
compared to standard (hospital-centred) arrangements.Simulation modelling in schizophrenia:
unresolved cost issues
Stephen Almond
Introduction
It is now well established that long-term prospective clinical trials will provide the
most comprehensive data for cost-effectiveness analysis of new drug interventions
in schizophrenia, but to date few have been completed. In the absence of such
data, simulation models have been used to calculate the expected costs of treating
patients with schizophrenia for alternative drug therapies (Almond and
O’Donnell, 1998; Palmer et al., 1998; Sacristán, Gómez, and Salvador-Carulla,
1997). This type of model offers a convenient starting point for evaluating costs
but is usually subject to several limitations (Almond, 1998).
In this article, focus is placed on two significant cost aspects of simulation
modelling that have generated important but largely unanswered questions from
practitioners:
 Are changes in patient symptoms associated with real movements to different
types of accommodation?
 To what extent do expected cost savings transform into actual cost savings?
The concept of opportunity costs is discussed and this leads on to a brief account
of cost-shifting between different budgets. The final section briefly reviews the
role of prospective clinical trials and the extent to which they can provide answers
to these important modelling questions.
Accommodation movements
Figure 1 summarises typical costs fed into UK models of schizophrenia. The
significance of accommodation costs as a proportion of total average costs, and of
total average costs between different types of accommodation, raises doubts for
simulation model estimates. This is because changes in mental health symptoms
as a result of drug therapy are hypothesised to be associated with changes in
specific (assumed) packages of care made up of service and accommodation
costs. If patients remain in their current residence, only changes in service
utilisation can vary. If they move, service utilisation can vary but there may be
some confounding associated with the type of accommodation and its staffing
level.
Using the simulation
approach, a patient
can be transferred
between different
accommodation
types as symptoms
change, which in
turn will be
associated with a
change in costs. But
it would be both
impractical and
clinically ineffective
for a patient
continually to move
residence according
to their current
10 Mental Health Research Review 6, May 1999
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Figure 1 Average 6 month costs (£) for patients with schizophrenia by
category of care, 1997symptoms. In general, if a patient is not repeatedly relapsing they are more likely
to be left in their current residence.Does this mean that simulation models estimate
unlikely changes in costs?
This would be true if accommodation costs in a model are always adjusted to
reflect changes in patient symptoms when in fact there is little or no movement
between different types of accommodation.
However, because a model is a simplification of real world events, and in the
absence of real data, one option is to ensure that differences in accommodation
costs are set at a conservative level for different mental health symptoms. This
will reduce any possible bias when evaluating the cost-effectiveness of alternative
drug therapies. Another option would be to exclude movements in
accommodation altogether, but this would go against the grain of the simulation
approach — designed in principle to show possible new (long-term) events from
new therapies. The best option is to use sensitivity analysis to test for zero
changes in accommodation costs.
There is currently no published literature to show the extent of movement
between different types of accommodation, or in general the extent to which
patients can be moved to alternative accommodation, following improvements in
symptoms by drug therapy. There is probably always more flexibility in the
decision to send patients home, especially if there is available family support,
than to transfer patients to another type of accommodation.
There is some unpublished evidence to suggest that patients do not really have
the option to move freely between different types of accommodation, even in the
event of significant changes in symptoms (Almond and Byrom, 1999). In a
small-scale survey, psychiatrists were asked to hypothetically place patients in
various types of accommodation conditional on experiencing positive and
negative symptoms, first taking into consideration local supply conditions and
then relaxing this constraint. The overall conclusion from this survey suggests
that, for most combinations of positive and negative symptoms, psychiatrists were
more likely to place patients at home but ideally would have liked to have placed
them in various supported accommodations and, surprisingly, relatively more to
long-stay in-patient care. However, the low sample size (n=11), the Delphi panel
nature of the survey and the use of limited health outcome criteria, make it
difficult to generalise these results.
Is service utilisation ‘accommodation-driven’? Figure 1 also highlights an
inverse relationship between accommodation and service utilisation costs. This is
reflected by the fact that accommodation costs increase with staffing levels, and
higher levels of support can reduce the need for certain key services, such as
community psychiatric nurse, GP and social worker visits, etc.
As noted above, this leads to some confounding in simulation model estimates,
related to whether changes in service utilisation are driven by changes in drug
therapy or whether they are associated more with changes in the type of
accommodation and staffing levels. If patients do not generally move between
different types of accommodation, as suspected, this means that changes in
service utilisation can be attributed (but not exclusively) to drug therapy with
more confidence.
Expected and actual cost savings
The debate over the comparison between savings in expected and actual costs
relates to both services and accommodation. It is particularly important for the
high potential savings in hospital costs associated with lower relapse rates from
new atypical drug therapy in schizophrenia. Policy makers and practitioners
question whether expected cost savings actually transform into real cost savings.
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therefore unlikely to ‘disappear’ from the NHS system. For example, if an
in-patient bed becomes available because of effective drug therapy, it is likely to
be occupied, very quickly, by another patient. In fact, if the new patient is in an
acute stage of schizophrenia, costs may even rise. This argument is real and it is
difficult to defend simulation results from an accounting point of view.
However, economists argue that costs derived in a model should be viewed as
opportunity costs and not pure accounting costs. This is because even if actual
savings are not realised in a pure money sense, resources can be switched to their
next best alternative use — suggested by the practitioners’ argument to be the
next patient. This is central to basic economic theory — the efficient allocation of
scarce resources. And even if real cost savings are made, it is difficult to justify
the concept of ‘savings’. This is because the best course of action could well be
associated with an increase in the supply of a factor that is currently scarce, such
as the availability of an in-patient bed. In the long run, of course, actual savings
would be associated more with total NHS expenditure than with individual GP
or hospital budgets.
Cost-shifting What is perhaps of more interest to practitioners with regards to
actual cost savings is not the concept of opportunity costs but the debate over
‘who saves what’ — or the extent of ‘cost-shifting’.
Cost-shifting refers to a situation in which one budget-holder incurs greater costs
in treating a patient but the benefit of savings goes directly to another
budget-holder. For example, if GPs prescribe a more expensive atypical drug for
schizophrenia and this leads to lower hospital costs from lower relapse rates, their
budget comes under pressure but the hospital budget benefits. Unless budget
formulae are adjusted or centralised, cost-shifting will remain a problem. In
theory, simulation models can be tested for cost-shifts but as yet there is no
published evidence.
Prospective clinical trials: do they provide answers?
Prospective clinical trials record economic data alongside clinical outcomes. This
unitary source of data therefore provides a direct relationship between changes in
symptoms and service utilisation patterns, including whether the patient actually
does transfer to alternative accommodation. And more important, this pattern of
utilisation is recorded for each drug prescribed. These are the main benefits of
this type of trial, and deal with most of the limitations in simulation modelling.
Yet as far as actual or real cost savings are concerned (expected costs are not
relevant for actual data), prospective clinical trials will still not provide this
information, which from a policy perspective may be disappointing. This would
definitely be the case if real cost savings were made in a future time period (for
example, the closure of a ward or hospital). Also, to measure the opportunity
costs in a clinical trial would be a complex and time-consuming process — and
unlikely to be included in the methodology of future prospective trial protocols.
Conclusion
Simulation models provide useful ‘starting point’ estimates of the average costs of
schizophrenia for patients treated with new atypical drugs. However, there must
be caution when incorporating assumed packages of care in these estimates
because of possible bias in the final results. This is particularly true for one of the
most important cost aspects of the model — changes in accommodation status.
Expected cost savings cannot be interpreted as actual cost savings. Economists
argue that opportunity costs are more important and intuitive than financial
costs, but admit they are difficult to calculate and would be difficult to
12 Mental Health Research Review 6, May 1999incorporate in future prospective trials. The debate on cost savings is enhanced
by concerns about cost-shifting processes.
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Key points
 Simulation models calculate the expected costs of schizophrenia in the absence of real data and
differ from models concerned with actual costs.
 Accommodation costs dominate total average costs but there is some doubt as to their relevance
in simulation modelling due to movement questions.
 Actual cost savings come under scrutiny but should be examined in terms of opportunity costs
and the ability to increase the supply of services.
 Cost-shifting means that the original purchaser of treatment may not experience the benefits of
savings.
 Prospective clinical trials will provide superior data but are unlikely to identify opportunity costs
and the extent of ‘cost-shifting’.
Economic evaluation of treatment for elderly patients with depression:
a comparison of sertraline, placebo and patients who discontinue
therapy
This economic evaluation is based on a prospective clinical trial that examined long-term maintenance
treatment with sertraline as prophylaxis against relapse and recurrence of depressive symptoms for elderly
patients. The trial consisted of four discrete phases. Phases I and II used open label sertraline for durations
of 8 and 12 weeks respectively. Phases III and IV were double-blind placebo controlled for durations of 48
and 52 weeks respectively. Clinical outcomes were measured using the MADRS. A wide range of services
was included in the economic analysis. The unique feature of this trial is the follow up of both clinical and
economic outcomes for patients who discontinued therapy. Results from this evaluation are currently in the
process of journal submission. Clinical and economic outcomes were compared for patients treated with
sertraline and placebo and those who discontinued therapy. These comparisons were carried out for patients
who started and completed phase III and then for patients who stayed in the trial until the end of phase IV.
For further information, please contact Stephen Almond.Costing different models of mental health
service provision
Paul McCrone, Daniel Chisholm and Martin Bould
Introduction
The national policy shift towards more community-based mental health services
has led to increased efforts by health and local authorities to assess current levels
of provision across a range of service areas, to examine the extent to which
identified local needs are being met by these services and to consider the
resource implications associated with required or planned changes in the future
configuration of services.
This article describes one recent attempt to model the costs of a range of mental
health care strategies in an outer-London health authority. The perceived value of
this modelling approach to service costing was to supply insights into and
estimates of broad directions of change, which could subsequently inform a wider
discussion between local clinicians, planners and managers about future mental
health services in the locality.
Method
The approach taken to model the estimated cost implications of pursuing
alternative mental health service strategies was intended to provide an explicit
framework for discussing local options for change. A series of steps was followed:
Step 1: Identification of mentally ill sub-populations
The various models related to the entire adult and elderly population of the
health authority, within which we identified three key mentally ill
sub-populations (to which prevalence rates were applied):
 adults with a serious mental illness (SMI), subsequently divided by CPA levels
1-3;
 adults with common mental disorders (CMD), distinguished according to the
two main diagnoses of depression and anxiety; and
 elderly people with a mental illness (EMI), split into organic (dementia) and
non-organic disorders (psychoses and affective disorders).
Step 2: Attachment of service utilisation profiles to each user group
Services included: psychiatric in-patient and out-patient care; day care attendances;
contacts with a GP, CPN and social worker; practical community support (home
care, drop-in centres, etc.). Contacts that individuals have with CMHT workers
are included under the specific type of professional. Other service components
including residential care and rehabilitation services were excluded from this
particular analysis, and were assumed to remain constant at currently planned
values for each of the models. For each component and client group, the
following data were estimated, drawing on a number of sources, including
completed research surveys or studies for the various sub-groups (see table 1):
 the proportion of sub-groups who use each service component (%), and
 the average amount of use per year for those who do access these services (N);
Step 3:Costing of service utilisation profiles
Unit costs associated with each service component were obtained from previously
calculated local or national estimates (Netten and Dennett, 1997; Chisholm,
Lowin and Knapp, 1997) and applied to the estimated profiles of service use.
Annual costs of care were estimated for each user group and for the whole
mentally ill population.
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The estimation of costs for a baseline model (representing the status quo)w a s
followed by the introduction of the following additional or substitute service
models, in order to observe the effect of predicted changes to patterns of service
delivery on existing costs of provision:
 alternatives to existing in-patient hospital provision (The Bungalow ( Hodgson
and Lewis, 1997); Day Hospital (Creed et al., 1997));
 crisis care and assertive outreach models (Crisis House (Beck et al., 1997));
Daily Living Programme (Knapp et al., 1994); Intensive case management for
‘hard to engage’ patients (Holloway and Carson, 1998); Hospital at home
(elderly) (Williams, Ellis and Hardwick, 1997));
 comprehensive community-based mental health care models (Partial
hospitalisation — The Grange (Scott, McCluskey and Smith, 1995)).
Results
Subsequent to the application of prevalence rates and unit costs, the estimated
service cost associated with the set of service packages given in table 1 were
calculated to be £9.43 million per 100,000 population aged over 15 years
(1996/97 prices). The single largest component of cost is care for dementia (over
£4 million p.a., at an average cost per user of £3072). The most
resource-intensive group, as expected, is the SMI group, with mean costs per user
rising from £2114 for CPA Level 1, through £4525 for CPA Level 2 to £6999
for the small number of CPA Level 3 users. Common mental disorders account
for only £0.67 million of the overall costs per 100,000 population aged over 18
years.
There are modest but significant cost implications associated with the
introduction of the modelled scenarios across the authority (figure 1). All but one
of the models offer a lower overall cost of care, in spite of the cost of their
implementation. The most favourable models are ‘The Grange’, the ‘Daily Living
Programme’ and ‘Hospital at Home’ (all reduce overall costs by between 2.5 and
4.5%). The impact of particular models on specific user groups is more
pronounced; for example, The Grange model was associated with more than a
20% reduction in the estimated costs of care for the SMI group. (To illustrate,
this significant reduction is due to the fact that 30% of potential admissions
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Table 1 Estimated contact rates for an adult and elderly mentally ill population
Sub-group In-patient
(days)
O/P psych.
(visits)
Day care
(visits)
GP
(contacts)
CPN
(contacts)
Soc. work
(contacts)
Comm. care*
(contacts)
% N % N % N % N % N % N % N
SMI
 CPA 1
 CPA 2
 CPA 3
CMDs
 Depression
 Neuroses
EMI
 Affective
 Psychoses
 Dementia
15
30
30
1
0.3
3
1
15
30
60
90
20
10
30
50
100
75
75
80
9
5
20
20
2
4
6
12
6
6
6
6
6
30
40
50
5
0
20
20
30
100
70
80
25
0
50
100
50
60
60
60
50
60
50
50
50
6
8
10
12
12
12
6
12
50
70
60
9
5
5
50
5
12
20
25
12
12
6
12
12
10
20
30
5
0
10
10
10
6
12
25
25
0
50
50
25
10
20
30
1
0
20
20
40
50
75
100
50
0
100
100
100
* Practical community support (incl. domiciliary support, drop-in centres etc.)could be dealt with by partial hospitalisation, length of stay could be reduced by
60% and only 38% of patients referred were admitted to full hospitalisation
(Scott et al., 1994).
Implications
The findings presented need to be seen in the light of key assumptions made
during the modelling process:
 transferability of models (will models developed successfully elsewhere have a
similar impact in a new population or area?);
 independence of models (service models have been treated as independent
entities, rather than in combination);
 relationship of models to unmet need (models do not make any assumptions
about underlying levels of unmet need);
 start-up costs of models (the financial — as opposed to economic — costs of
implementation, particularly capital costs, need to be taken into account).
These assumptions and limitations can be addressed in a number of ways at a
local level, for example by carrying out a needs assessment exercise, an audit of
actual service utilisation profiles in key user groups or a more in-depth option
appraisal of selected models.
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Compliance therapy
As part of a Medical Research Council funded randomised controlled trial conducted by researchers at the
Department of Psychological Medicine, Institute of Psychiatry, CEMH carried out a cost-effectiveness
evaluation of a new therapy for improving medication compliance amongst people with a psychosis. The
main conclusions from the study are summarised below:
 Compliance therapy was found to be effective over 18 months when compared to non-specific counselling.
It is also cost-effective.
 Although there were no apparent differences in the cost implications associated with each intervention,
compliance therapy was found to be more a more clinically effective intervention as measured along
selected scales of outcome.
 There may therefore be economic as well as clinical grounds for extending the availability of compliance
therapy.
There were however some caveats attached to the conclusions reached:
 Wide cost variations and sample attrition meant there was insufficient power to test for statistical
significance.
 Cost-effectiveness results relate to a sample of patients receiving compliance therapy in a psychiatric
in-patient ward, and may not be generalisable.
 The evaluation ran for 18 months; improvements in compliance over this period may not have their full cost
impacts until rather later.
Full details of the economic study can be found in:
Healey, A., Knapp M.R.J., Astin, J., Beecham, J., Kemp., R., Kirov, G. and David, A. (1998) Cost-effectiveness
evaluation of compliance therapy for people with psychosis. British Journal of Psychiatry, 172, 420-424.
Training family support workers to relieve carer burden
The aim of this study is to assess the impact of a training programme on the ability of family support workers
(FSW), employed by an independent sector organisation, to relieve the burden on carers of people with
schizophrenia. Half of the FSWs have been randomly allocated to receive the training programme. Cases
referred to the experimental and control group are assessed in terms of carer stress, needs, burden, quality
of life, cost of care and service satisfaction, and these measures are repeated at the end of the intervention
period. If successful, the training programme will be offered to the control workers and then disseminated
more widely.
This research began in January 1997 and is due to be completed by the end of November 1999.
Enquiries should be directed to Ann Davies, Research Associate, Department of Psychiatry, University of
Manchester, Mathematics Building, Oxford Road, Manchester M13 9PL. Telephone: 0161 275 5221, Fax:
0161 275 3924.Survey of day activity settings for people with
mental health problems
Jennifer Beecham, Justine Schneider and Martin Knapp
Introduction
In 1997, the Personal Social Services Research Unit, funded by the Department
of Health, conducted a postal survey of day activity settings for adults with
mental health problems in the South Thames NHS region. Day activity services
form a central component of support packages for people with mental health
problems yet, while the number of settings has increased considerably since the
previous large-scale survey (Carter, 1981), there are still no centrally-compiled
registers of day settings from which a ‘map’ of service provision can be created.
For the purposes of this study the term day settings refers to any facility (for
example, day hospital, day centre or work-related scheme) which typically
provides social or practical communal support and which has paid volunteers or
staff present in a non-domiciliary and non-residential capacity.
When the survey was undertaken, the South Thames area was one of eight health
regions in England, with a population of just under seven million. Health services
were purchased by twelve commissioning authorities, each of which served a
population of between 300,000 and 938,000. There were 64 NHS Trusts. Day
activity services were also provided by the social services departments of four
county councils and twelve London boroughs and numerous voluntary
(non-profit) organisations.
Various sources of information were used to obtain the contact
names and addresses of day activity settings for people with
mental health problems. Of the 308 addresses identified in the
South Thames region, 45 were found to serve other client
groups or had closed and two were organisation headquarters.
This left 261 valid addresses of which 60% (155 settings)
completed the postal questionnaire (see box 1).
Location
Predominantly, the settings in our sample were located in
urban areas, either town centres or residential areas (85%).
Forty-one per cent of the day activity services were located on
stand-alone sites, separate from other service providers.
Thirty-seven settings were linked to community mental health
teams or other mental health services and 28 settings were based in other
provider units such as residential homes or hospitals.
Size and opening
Between 110 and 120 settings recorded attendance figures for the morning and
afternoon sessions on Monday to Friday with an average of 23 people attending
each session (median 20). Far fewer settings were available in the evenings: 24
settings were open on Wednesday evenings, 14-19 settings were open Monday,
Tuesday and Thursday evenings, but only eight settings were open on Friday
evenings. On average, 25 settings were available during the day on Saturday and
Sunday but only four were open in the evenings at weekends.
Only a dozen or so settings did not keep a register of users, and the
accompanying documentation usually identified these as drop-in centres or as
having an ‘open access’ policy. For the 44 settings which had an active waiting
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Box 1 Questionnaire coverage
 identification of the setting;
 a broad description of location and
agency links;
 number of staff, their training and
working hours;
 the types of support provided within
the setting;
 income sources and expenditure for
1996-97; and
 information about the users of the
setting.list, there were between one and 60 people on the waiting list (mean twelve
people, median eight people).
Over the last ten years, an average of ten settings have opened each year.
Forty-three settings in our sample had been open longer than ten years and 44
had been open more than five years.
Staffing
About half of the settings employed social care staff on-site and a quarter were
staffed by nurses. Occupational and other therapists were employed in 35 and
nineteen settings respectively, but a surprisingly low number of settings were
supported by either psychiatrists or psychologists (eleven settings).
Three-quarters of the settings had management staff on-site but only a quarter
had administrative support. Only 36 settings reported having staff vacancies.
Integration with the wider community
Sixty-nine respondents said the building was used for other activities when the
day service was not open. A total of 113 activities were recorded; 39% of these
activities were related to mental health (for example, stress management, anxiety
or eating disorder support groups); 17% were services for other client groups or
staff (such as elders’ groups, craft groups for visually impaired people); and
activities used by the wider community formed the remainder (such as leisure
activities or slimming groups).
A quarter of settings reported they were noticeably or fully integrated with
leisure, employment or education services for people without disabilities, but
about a third said they were not at all integrated with such services. However, 64
settings (41%) recorded the details of 205 other local day activity settings with
which they had contact.
The availability of transport can have a large impact on the opportunities open to
people. When asked how well the setting was served by public transport
 130 settings said they were adequately served by public transport, 50 of which
also provided transport to and from the setting;
 Twenty settings said they were poorly served by public transport, twelve of
which provided transport; and
 Three settings said there was no public transport in the area and transport was
provided by all of these settings.
Sector and orientation
Respondents were asked to identify the sector and principal orientation of their
setting. Both data were available for 133 settings, and table 1 shows an expected
pattern of associations: all bar
one of the settings principally
orientated towards providing
treatment were managed
within the health sector, and
those primarily providing
social support were more
commonly managed by social
services departments or
non-profit sector
organisations. Settings
principally providing work
tended to be managed within
the non-profit sector.
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Table 1 Sector and principal orientation
Principal
orientation
Sector / managing agency N
LASSD
a NHS
Trust
b
Non-
profit
c
Treatment 1 30 0 31
Social support 24 9 39 72
Work 3 9 18 30
Total 28 48 57 133
Notes
a. Local authority social services department.
b. Specialist mental health, hospital or community Trust.
c. Voluntary and other not-for-profit organisations.Content of services
Respondents were also asked to say whether or not they provided any of the
eleven types of support identified in the WHO International Classification of
Mental Health Care (de Jong, 1997). This schedule provides a measure of service
content by identifying what groups of professionals do to groups of patients.
All settings provided more than one of these types of support. Figure 1 shows
that most settings provided help for users to establish and maintain relationships,
problem assessment, (re)education in daily living, interpersonal or social skills,
and help for users to spend their days in ways worthwhile to them. However, only
about a third of settings provided interventions to support family members and
only a quarter supervised medication. These data clearly show that day settings
provide a multi-faceted service, but different mixes of support are provided by
different settings. This type of information can help referrers ensure that users
receive a service that meets their individual needs for support. Although many of
the types of support identified by the ICMHC modalities could be seen as
secondary functions, they still provide important components in the care of
people with mental health problems. For example, although half of the settings
said they provided work-related activities, only 30 settings mentioned work as the
principal orientation of their setting.
Characteristics of regular users
Each setting was asked how many people with mental health problems use the
setting regularly each week. Of the 155 respondents, 148 answered this question,
reporting a total of 7466 users.
Typically, the youngest regular users were aged between 16 and 20 years old. For
83 settings (54%) the oldest users were between 45 and 65 years. However, even
though the survey excluded settings catering specifically for elderly people with
mental health problems, 66 settings were used regularly by people who were
between 66 and 100 years old.
Broad indicators of the characteristics of the regular user group were also
requested. Although the number of settings which provided data varied for each
domain, these characteristics of the full regular user population were determined:
 3 per cent of regular users normally live in a hospital ward;
 13 per cent have been in hospital for psychiatric care in the last three months;
 17 per cent live in staffed accommodation;
20 Mental Health Research Review 6, May 1999
87
65
57
34
42
23
52
70
50
64
36
Help for users to establish and maintain relationships
Assessment of users’ problems or functioning
Co-ordination of other care services for users
General health care
Undertaking daily living activities for users
Prescription or supervision of mental health medication
Psychological interventions (for example, group work or counselling
(Re)education for users in daily living, interpersonal or social skills
Work-related activities
Helping users spend their days in ways which are worthwhile to them
Interventions to support family members
0 2 04 06 08 0 1 0 0
Per cent of settings providing this type of support
Figure 1 Types of support provided within the settingsMental Health Research Review 6, May 1999 21
 41 per cent are taking regular neuroleptic medication;
 6 per cent are subject to a Mental Health Act section;
 14 per cent are former long-stay hospital patients; and
 37 per cent have some additional problem such as physical illness or disability
(13 per cent), aggressive or disruptive behaviour (7 per cent), use of illegal
drugs (7 per cent) or misuse of alcohol (10 per cent)
The costs of day activity settings
Using information on revenue expenditure, costs were estimated for 122 of the
settings in the sample. Revenue costs per annum range from £3200 to £450,000
around a mean expenditure of £109,700 per annum (median, £88,800). To
facilitate cost comparisons an average cost
per user session was estimated for each
setting to take into account the number of
users and the number of sessions each
setting is open. Revenue costs per user
session are between £0.88 and £68.26
around a mean value of £11.65 (median
£9.16). Costs variation was found to be a
result of the services each setting provided
(as measured by the types of support and
principal orientation) rather than the
management sector per se. Table 2 provides
some descriptive information on the
variation in revenue costs found as a result
of their orientation.
Justine Schneider was formerly at the PSSRU and is now at the Centre for Applied Social
Studies, University of Durham.
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Key points
 Most settings are located in urban areas or towns.
 Most are only open during weekday working hours.
 On average 20 people attend each session.
 Day activity services still tend to be closely linked with other specialist services yet few receive
support from psychiatrists or psychologists.
 A quarter of the settings are principally orientated towards providing treatment but most settings
provide between five and eight types of mental health support.
 Mean revenue costs are between £0.88 and £68.26 per user session.
Table 2 Revenue costs per user session by
principal orientation
Mean cost per
user session
a
95% C.I. N
Treatment £19.29 £14.40 – £24.19 27
Social support £7.34 £6.01 – £8.67 61
Work £12.53 £9.59 – £15.47 21
Other
b £14.52 £8.01 – £21.03 13
Notes
a. 1996-97 prices.
b. Includes those settings which said their main orientation was
towards social support and work or treatment, and those
settings which listed specific attributes of the service (n=5).22 Mental Health Research Review 6, May 1999
South Leeds Evaluation
In 1994, CEMH was commissioned to work alongside the Community Care Division of the Nuffield Institute,
University of Leeds, to provide data on the cost implications of a new acute mental health service developed
for residents living in South Leeds and to analyse the balance of inter-sectoral expenditures on all mental
health services in the same location.
A more detailed description of the study and results can be found in the Nuffield Institute for Health
Community Care Division Working Paper 7.
(Information and Admissions Office, Nuffield Institute for Health, 71-75 Clarendon Road, Leeds, LS2 9PL.
Telephone: 0113 233 6942; website: http://www.leeds.ac.uk/nuffield/; email
nuffield@leeds.ac.uk)
The main conclusions reached are summarised below:
 Cost-related data were collected and analysed for people primarily supported during their acute episode
by the in-patient service in Ward 42 at St James’ Hospital or the Intensive Home Treatment Team (IHTT) –
a home-based acute care service. The average acute care cost for the IHTT (n = 22) and Ward 42 (n = 24)
samples was £2606 and £3615 respectively. The parallel service outcome evaluation indicated that users
of the IHTT viewed their treatment more positively than did the in-patients.
 The sample members used a broad package of hospital- and community-based services in the 12-month
period prior to and 18-month period subsequent to their acute episode. It is important for health care
purchasers and providers to consider the delivery of specific psychiatric interventions in the context of the
total support requirements for people with mental health problems. These include housing, income (often
obtained through receipt of social security benefits), occupation and meaningful day activities, mental
health care provided though other agencies and services, generic health and social care services, and the
support provided by relatives and friends.
 In 1994/95 over £5 million was spent on mental health services in South Leeds. The health sector was
responsible for only half of this expenditure through the Trust’s delivery of acute services and those
providing longer-term support. The local authority social services department and voluntary sector
organisations also play important roles, mainly in the provision of residential and day care services. There
was some evidence of inter- and intra-agency working within this mixed economy of mental health care but
improved communication between the organisations about their roles and activities and the separate and
joint financial contributions may enhance the linkages between the component parts of the mental health
care system. There should also be adequate recognition of the important role played by the primary care
services.Child and adolescent mental health services
in Brixton and Croydon
Daniel Chisholm, Patrick Byrne and Carla Croft
Policy context
There has been increasing policy focus on containing the short- and long-term
costs of childhood disorders to the individual and to society by increasing
provision of early intervention services (Beitchman, Inglis and Schachter, 1992;
Light and Bailey, 1993). In spite of the significance of economic considerations in
the treatment and prevention of child and adolescent mental health problems,
previous epidemiological investigations have been largely confined to the study of
mental health among the individuals concerned, rather than the broader and
more long-term public health and economic aspects. Consequently, there is only
a small body of research in child mental health care that incorporates a cost
dimension or addresses comparison of cost-effectiveness between treatment
modes (Knapp, 1997; 1999).
The Brixton – Croydon CAMHS study
The aims of the study, funded by the NHS R&D Programme and carried out in
two child and adolescent mental health services in Croydon (Dr Patrick Byrne)
and Brixton (Dr Anula Nikapota), were threefold:
 to develop a system for the evaluation of child and adolescent mental health
services (CAMHS), based upon a battery of measures of process and outcome;
 to assess the reliability and validity of these measures by the criterion of
detailed and explicit research interviews;
 to collect data on all services and supports which children in the sample
receive, in order to calculate the costs associated with the two models of service
delivery.
The sample consisted of children of both sexes aged 5 to 11 years inclusive who
attended at least one out-patient session at the two centres in Brixton and
Croydon with disorders of emotion or conduct. A small number of children who
had pervasive developmental disorders, severe learning disability or eating
disorders were excluded from the study. A range of clinician and researcher-
administered measures were employed (box 1). The focus of the economic
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Box 1  Summary of measures
Administered by clinicians
At first contact: Demographic Data, Clinical Problems checklist, ICD 10 Diagnosis, Case complexity/severity;
Child/parent problem priority; Treatment plan and goals.
At final contact (case closure): Administrative status; Interventions checklist; Clinical change — symptom
outcome; Outcome of treatment: 1) 3 Specific aims, 2) Global outcome, 3) Degree of Completion, 4) Brixton
Psychosocial Outcome.
Administered by researcher
At first contact: Strengths and Difficulties Questionnaire (SDQ); Parental Account of Children’s Symptoms
(PACS); Client Service Receipt Inventory CSRI – C); Parent Consumer Satisfaction Questionnaire. Teacher
version of SDQ sent by post to child’s school.
At final contact: Repeat above; repeat clinical dataset outcome measures; postal questionnaire to referrers on
outcome; teacher SDQ repeated by post.analysis was to observe differences over time, rather than between the two
services. This has enabled inferences to be drawn with respect to the impact of
specialist child mental health services on costs and outcomes.
Costing methods Measures of direct cost were based on service utilisation data
obtained for the pre-referral period (previous twelve months), and for the
following five months of the treatment period (for many children, this
represented case closure). Service utilisation data were collected retrospectively,
using an adapted and recently piloted version of the Client Service Receipt
Inventory (CSRI-C; see Knapp, Scott and Davies, 1999) that is integrated with
the demographic section of the Parental Account of Children’s Symptoms
(PACS). Costs were calculated for each service using previous research studies
and nationally collated unit cost data (Netten, Dennett and Knight, 1998). All
costs relate to the financial year 1997/98. Service utilisation and cost data were
combined in order to generate estimates of total and component costs for each
sampled individual, subsequently aggregated into scores for the two sites. Costs
were divided into four categories (paediatric hospital services; health and welfare
services; child day services; and child mental health services), in order to observe
changes in the distribution of costs between different agencies and service types.
Data on the input from family members were also collected.
Preliminary service cost results The monthly costs of each of the four service
categories are given in figure 1. Monthly costs of child mental health services
increased significantly in both areas over the period of study, reflecting the
additional inputs provided to meet the needs of the children. There is also a
statistically significant increase (at p<0.05) in the cost of health and welfare
services, from £49.59 to £73.99 in Brixton, and from £44.60 to £56.39 in
Croydon. In Brixton, there were also slight increases in cost for paediatric
hospital services and child
care day services (though
not statistically so),
whereas in Croydon there
were modest decreases in
cost. The overall service
cost per month increased
significantly in both areas,
from £90.55 to £156.46
in Brixton (p<0.01) and
from £92.71 to £115.11
in Croydon (p<0.05).
The description of costs
in isolation of other
characteristics of the
sampled population can
hide underlying
relationships that may
have an important bearing on service needs and costs. Bivariate and multivariate
relationships are therefore being explored, both for service costs in their totality
and for child mental health services specifically.
Impact on families and informal carers An important consequence of child
mental health problems is the impact on families. The effect of the child’s
behaviour on the careers of principal carers was considerable. Overall, 33% of
principal carers (nearly all mothers) reported that their career had been affected
in some way in the year preceding intake, a proportion that only dropped to 27%
at the follow-up assessment five months later. The most common effects were
disturbance at and enforced absence from work, but a small minority (less than
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Figure 1 Service costs per month, by service type and centre at
intake and closure5%) of principal carers also indicated that they had actually lost their job as a
result of their child’s behaviour. The impact on the careers of the principal carer’s
partner (where applicable and where information was offered) appeared to be
much less intrusive. No instances of jobs lost were reported, but absence from
work had affected a small number of partners.
The costs specifically associated with service utilisation by other family members
as a result of the index child’s behaviour were computed. In the year prior to
intake, 40 households (covering 50 of the sampled children) reported that they
had taken up services as a result of the child’s behaviour, compared to 22
households (32 children) over the follow-up period. A range of services was used,
including GP consultations, social services, out-patient attendances and
counselling. For households with more than one child in the study, the costs of
these services were allocated pro rata. The summed cost for the year prior to
intake was £22,384 (or £9327 for a five month period), compared to £4840 for
the follow-up period. Mean costs were £187 (sd 725) and £151 (sd 193) for the
five months preceding intake and closure respectively. There therefore appears to
be a clear additional burden placed on statutory services by other household
members directly as a result of the child’s behaviour.
Conclusion
Alongside the comparison of clinician and researcher ratings for a range of
outcome measures, the economic component of this study of children referred to
child and adolescent mental health services has demonstrated the considerable
impact that childhood mental disorders impose on a range of service providers as
well as informal carers. Since economic studies of childhood mental disorders are
still at an early stage of development, there are also important methodological
lessons to be learnt from the conduct of this study, including specification of the
set of services with which children and their families are in contact. Further
analyses of the inter-relationships between costs and outcomes are now being
explored, with a view to assessing the extent to which changes in the clinical
status of the children (as a result of their contact with specialist psychiatric
services) are associated with altered patterns of service utilisation across the
range of service sectors assessed.
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Key points
 Previous CAMHS research has been largely confined to the study of mental health among the
individuals concerned, rather than the broader and more long-term public health and economic
aspects.
 The Brixton-Croydon CAMHS study has enabled inferences to be drawn with respect to the
impact of specialist child mental health services on costs as well as outcomes.
 The overall service cost per month increased significantly in both areas, reflecting the additional
inputs that are being provided to meet the needs of the children. The extent to which changes in
the clinical status of the children are associated with altered patterns of service utilisation
across the range of service sectors is being assessed.Knapp, M.R.J. (1999) Economic evaluation and conduct disorder, in J. Hill and B. Maughan,
Conduct Disorders in Childhood, Cambridge University Press, Cambridge.
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Quality and costs of residential supports for people with learning
disabilities
In 1996 the Department of Health commissioned the Hester Adrian Research Centre (University of
Manchester) and the Centre for the Economics of Mental Health to undertake a two-year project investigating
aspects of the quality and costs of residential supports provided to people with learning disabilities. Following
this, the Irish Department of Health commissioned the Centre for the Study of Developmental Disabilities
(University College, Dublin) to undertake a parallel project in Ireland using the same protocols for data
collection.
The programme of research investigated the characteristics and needs of, supports provided to, and
outcomes experienced by 560 people with learning disabilities. Four types of residential provision were
covered by the study. These were:
 five village communities operated by independent sector organisations. None of these services had been
developed as a direct result of the retraction and closure of NHS learning disability hospitals. Three of
these facilities were in England and two were in Ireland.
 five residential campuses operated by NHS Trusts. All of these services had been developed as a direct
result of the closure of NHS hospitals, and all were in England.
 community-based group home schemes.
 community-based supported living schemes.
Ten community-based provider organisations participated in the project. Of these, seven were operated by
independent sector organisations and three by NHS Trusts. Five of the ten organisations provided
accommodation in group homes and supported living schemes. All these organisations were in the United
Kingdom.
The project was completed in January 1999. The following reports have been submitted to the Department of
Health and will shortly be available in the public domain.
Emerson, E., Robertson, J., Gregory, N., Hatton, C., Kessissoglou, S., Hallam, A., Knapp, M., Järbrink, K.,
and Netten, A. (1999).
Quality and costs of residential supports for people with learning disabilities:
a) A comparative analysis of quality and costs in village communities, residential campuses and dispersed
housing schemes
b) A comparative analysis of quality and costs in group homes and supported living schemes
c) An observational study of supports provided to people with severe learning disabilities in residential
campuses and dispersed housing schemes
Hester Adrian Research Centre, University of Manchester.
Emerson, E., Robertson, J., Hatton, C., Gregory, N., Kessissoglou, S., Hallam, A., Knapp, M., Järbrink, K.,
Netten, A., Walsh, P., Linehan, C., Hillery, J. and Durkan, J. (1999)
Quality and costs of residential supports for people with learning disabilities:
a) Predicting variation in quality and costs
b) Summary report
Hester Adrian Research Centre, University of Manchester.
Copies of all reports and the instrumentation used in the project will be available from the Hester Adrian
Research Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, UK. Further details about
the costs study may be obtained from Angela Hallam at CEMH.Developmental language disorders: changing
economic costs from childhood into adult life
Judy Clegg and Juliet Henderson
Introduction
Twenty boys with developmental language disorders (DLD) have been followed
up from childhood into adult life. At their most recent follow-up interview the
DLD group were in their mid thirties. In addition to assessments of their
cognitive, social and mental health functioning, an economic assessment was
included. The economic costs of the DLD group are compared to their
non-language disordered siblings in order to control for family
background/functioning and genetics. The aims of the economic assessment are
to measure the cost of developmental language disorders within the domains of
education, employment and health from childhood into adult life. The
preliminary findings of the economic assessment are presented here.
Background
Developmental language disorders are characterised by a discrepancy between a
child’s non-verbal cognitive abilities and language functioning. Non-verbal
cognitive functioning falls within the normal range for the child’s age with a
deficit in language development usually shown by a poor performance on
standardised assessments of language functioning.
Although traditionally viewed as affecting young children, developmental
language disorders have been shown to have a persisting impact in middle
childhood, adolescence and adult life with respect to later language development,
communicative ability, scholastic achievements, employment, independence,
social functioning and mental health (Hall and Tomblim 1978, Cantwell, Baker,
Rutter and Mawhood 1989, Beitchman et al. 1994, DeAjuriagierra et al. 1976,
Mawhood 1995, Botting, Crutchley and Conti-Ramsden 1998). It is expected
that such consequences will have both direct and indirect economic costs, for
example, special educational provision needed in childhood and family burden
caused by a lack of the individual’s social and financial independence in adult life.
Knapp (1997) stresses the importance of long term follow-ups with an economic
dimension which focuses on the consequences in adulthood of childhood mental
health problems. These studies can provide information on the economic costs
incurred throughout an individual’s life. Such information is also relevant to the
study of developmental language disorders and therefore this study reports on
the direct and indirect economic costs of a follow-up of boys diagnosed with
developmental language disorder who have now reached their mid thirties.
Methodology
Participants Twelve of the DLD group and ten of the non-language disordered
siblings have so far been assessed. The mean age of the DLD group is thirty-five
years and nine months (sd 2.5). The mean age of the non-language disordered
siblings is thirty six years and two months (sd 4.2). The participants were
interviewed using the Client Service Receipt Inventory (CSRI). This comprises
two formats so that both the participant and an informant (preferably a parent)
can be interviewed in order to obtain the most reliable assessment. The CSRI
covers the areas of education, accommodation, health and employment. The
participants in the DLD group, the sibling group and the informants are widely
distributed throughout the UK.
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Educational provision and services Figure 1 shows that the mean costs for
the educational provision of the DLD group are £150,000 compared to £19,000
for the sibling group. (We have rounded the results reported in this article.) In
early childhood, between the ages of five and nine years, the entire DLD group
were in special educational provision, ranging
from boarding schools and day schools for
speech and language disorders or mental and
physical handicaps to language units of
mainstream schools. These schools provided
special needs services such as speech and
language therapy and special needs teachers.
This service pattern changed after the age of
nine years with seven of the DLD group
entering mainstream education whilst the
remainder stayed within special educational
provision. This pattern continued until the
entire DLD group left full-time education at
the age of sixteen years.
The mean costs of the sibling group were much
lower as they all attended mainstream
education where only two ever received special
educational services.
Employment The mean unemployment costs of the group are high due to their
histories of brief and temporary periods of employment. At the time of interview,
only four of the twelve members of the DLD group were employed. The sibling
group includes male and female siblings and therefore the employment status of
this group is complicated as four of the female siblings are in primary child care
roles. With this factor taken into consideration, only one of the sibling group has
been unemployed for a period of more than six months.
The mean total amount of lifetime benefits claimed by the DLD group was
£66,000. The lower sum of benefits claimed by the sibling group (£23,000) was
due to the sibling group having better employment records. The benefits
identified include unemployment, housing and disability benefit and income
support.
Accommodation Compared to the sibling group, the DLD group achieved a
lower level of independent functioning. Only six of the DLD group, but all of the
siblings, live independently. The remainder of the DLD group either live in the
parental home or in sheltered accommodation. The mean lifetime cost of
sheltered accommodation in the DLD group is £14,000 and zero for the sibling
group.
Health services The cost for the receipt of health services was calculated for the
twelve months prior to the interview. The mean costs for the DLD group was
£500 compared to £100 for the sibling group. Three members of the DLD
group have developed significant mental health problems in adult life and used
psychiatric services in the year preceding the assessment. This explains the higher
health service costs of the DLD group. The remainder of the costs for the DLD
group and those for the sibling group for GP services, opticians and dentists.
Conclusions
The preliminary findings show that within the domains of education,
employment, accommodation and health the economic costs of the DLD group
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Figure 1 Lifetime economic costs for DLD
and sibling groupshave been much higher compared to their non-language disordered siblings.
These results are consistent in both childhood and adult life. The high education
costs illustrate the burden placed on local education departments to provide
adequate educational support for these children. More rigorous statistical tests
will be used on the full sample. However, the initial results indicate that the DLD
group was overwhelmingly more expensive across all the cost categories.
The types of economic costs for the DLD group have changed from childhood
into adult life. In childhood, the direct costs incurred by special educational
provision were very high. In adult life, most direct costs arose from the amount of
benefits claimed and the receipt of psychiatric health services. The progression of
the DLD group into adult life also saw the emergence of indirect economic costs
to parents and carers caused by a lack of social and financial independence.
As the sibling group share the same parents and family background and have
incurred lower economic costs it is reasonable to conclude that developmental
language disorders are associated with persisting high economic costs from
childhood into adult life.
Correspondence: Ms Judy Clegg, Developmental Psychiatry Section, E Floor, South Block,
Queens Medical Centre, University of Nottingham, Nottingham, NG7 2UH. Telephone 0115
9709946, email Judy.Clegg@Nottingham.ac.; Ms Juliet Henderson, CEMH, email
sptejah@iop.kcl.ac.uk); Dr Chris Hollis, Developmental Psychiatry Section, E Floor, South
Block, Queens Medical Centre, University of Nottingham, Nottingham, NG7 2UH. Telephone
0115 9709946, email Chris.Hollis@Nottingham.ac.uk.
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Case study
At the time of assessment, TH was thirty-four years old. He was diagnosed with a developmental language
disorder in childhood. The case study clearly illustrates the changes in economic costs during his life.
Education
TH attended two boarding schools for children with speech and language disorders and then a boarding
school for mentally and physically handicapped children. At the age of eleven years, special educational
provision was no longer available for TH and he was mainstreamed into a local secondary school. TH then
received no further special educational services or speech and language therapy and left school when he
reached the age of sixteen years, having taken no exams.
Employment
TH’s first and only paid job was at the age of seventeen years where he worked as a print worker for two
years, earning £70 a week. After three years of unemployment TH undertook voluntary work at a coach
station for a year. TH’s main interest in life is coaches and therefore he did well, enjoying the position
immensely. However, no permanent contract was available at the end of the year and since then TH has not
worked.
Accommodation
TH has lived in the parental home with his mother for the majority of his life. At the age of twenty nine he
moved into a privately rented flat which he shared with the landlord. The landlord took advantage of TH and
overcharged his rent so that TH was forced to ask his sister and mother to help him out with a substantial
loan. TH was forced to move back into the parental home due to his inability to budget his finances
successfully.
When TH’s unemployment benefit was stopped he failed to tell his family and received no money for a period
of three months. Again, the family had to resolve the situation, which involved their time and money. Although
TH contributes all his income to the family household, his costs still need to be compensated for by his
mother’s income.References
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Key points
 There are high economic costs associated with developmental language disorders and these
persist well into adult life.
 The lower economic costs for the sibling group suggests that the high economic costs could be
specifically associated with DLD.
 The economic costs of the DLD group change, with the incidence of indirect costs increasing in
adult life.
 Direct costs also change from special educational provision in childhood to benefits and receipt
of psychiatric services in adult life.
The costs of social phobia and depression:
secondary analyses of the ONS Surveys of Psychiatric Morbidity
Anita Patel, Martin Knapp and Juliet Henderson
CEMH is currently conducting secondary analyses of the psychiatric morbidity surveys. The surveys provide
data on the prevalence of psychiatric disorders, services used by respondents, time off work and treatment
patterns. This work is focusing on (a) social phobia and (b) depression (with co-morbid anxiety). The aims of
the analyses are to:
 estimate the overall costs related to the two neurotic disorders
 examine sub-group differences in costs (for example, comparing those with just social phobia or
depression with those who have co-morbidities)
 examine treatment patterns (including use of prescribed medications) associated with each disorder
Results will be available in summer 1999.
Funding: SmithKline Beecham Pharmaceuticals.Community mental health care in low-income
countries: a role for health economics
Daniel Chisholm
The global burden of mental disorders
An accumulating body of evidence has emerged, particularly over the last five
years, which points to the massive burden that mental disorders impose upon
societies throughout the world. Four collaborative reports stand out in particular.
The first of these, a collaboration between the World Bank and the World Health
Organisation, entitled Investing in Health (World Bank, 1993), calculated that
neuropsychiatric disorders account for 8.1% of the global burden of disease (as
measured by disability adjusted life years). Despite the immense burden that this
report pointed to, it did not suggest that mental health should belong to the
package of essential clinical services. In the second collaborative report, the
Global Burden of Disease (GBD), compiled by the Harvard School of Public
Health, the WHO and the World Bank, the proportion of GBD caused by
neuropsychiatric disorders was revised upwards to 10.5% (Murray & Lopez,
1996). Psychiatric disorders account for five of the ten leading causes of disability
— unipolar depression, alcohol abuse, bipolar affective disorder, schizophrenia
and obsessive compulsive disorder. The burden imposed by neuropsychiatric
disorders is projected to increase to 15% of GBD by the year 2020.
The third report, Psychological Problems in General Health Care, is based on a
major WHO collaborative study in 15 primary care sites across both developed
and developing regions (Ustun and Sartorius, 1995). Overall, primary care
physicians identified 23.4% of attendees as being a ‘case’ with a psychological
disorder (while a research instrument identified 33%). Finally, World Mental
Health (Desjarlais, Eisenberg, Good and Kleinman, 1995) specifically concerned
itself with the burden of suffering imposed by mental and psychosocial health
problems on low-income countries. On the basis of the report’s findings, the
authors made a plea for mental health to be placed on the international agenda,
backed up by recommendations and specific initiatives for meeting the challenges
posed. The report was presented to the United Nations in 1995 and, following
the Director General’s response, the UN has set up a major initiative, led by
WHO, entitled ‘Nations for Mental Health’, the aim of which is to improve the
mental health of the world’s underserved populations.
The increasing recognition of mental health as a significant public health issue
has led to additional demands for resources that are already stretched. There is
therefore a requirement to demonstrate that investment is needed and
worthwhile, which translates into generating evidence on affordable and
cost-effective mental health care and prevention strategies. Such an evidence base
is an important step in convincing governments and international agencies that
additional mental health resources, most notably in training, drugs and basic
infrastructures, will generate significant health gain and other benefits.
Unfortunately, however, there is currently a dearth of cost and outcome data
upon which to base these decisions. The paucity of mental health economic
evaluative studies in low-income countries is a significant stumbling block to the
investment of resources in mental health by governments and international
agencies.
Mental health economics demonstration project in India and Pakistan
In collaboration with the Institute for Health Sector Development, London, the
Institute of Psychiatry, Rawalpindi (Pakistan) and the National Institute of
Mental Health and Neurosciences, Bangalore (India), CEMH has undertaken a
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(Chisholm et al., 1999). The end goal of the research can be stated as the
generation of cost and outcome data that will enable more effective, efficient and
equitable decision-making in the allocation of resources to mental health care.
Specific objectives included:
 the generation of a framework and accompanying guidelines for the conduct of
mental health care economic evaluations;
 a review of key issues relating to the structure, organisation, delivery and
financing of mental health care as they relate to low-income countries;
 the development and testing of protocols for the economic evaluation of
community mental health programmes.
The model of mental health care and prevention that is being most widely
advocated as the most appropriate way forward in many economically developing
countries is one that is integrated into the local community context, particularly
the existing primary health care system. The strengths of this approach include
the wide coverage that it can expect to attain, the holistic concept of health that it
engenders, and the low costs of its implementation. Our two collaborating
institutions have access to sites where the standard national package of primary
care is being delivered and sites where mental health activities are also included.
The design of the demonstration project was to recruit and follow-up a sample of
patients meeting ICD-10 diagnostic criteria for neurosis (largely depressive and
anxiety disorders) from two rural catchment areas in each site — one with
integrated primary/mental health care and a further locality with standard
primary health care. A two-stage process was employed for recruitment: first
screening for mental disorder via the Self Report Questionnaire (SRQ); then, for
all those scoring above the SRQ threshold for caseness, a psychiatric assessment
interview was administered. Only new episodes (as opposed to cases) were
included, defined as the presence of a set of symptoms for which no psychiatric
treatment had been sought in the last one month. Study subjects were informed
of their diagnosed health condition and invited to seek local treatment.
Research findings
The project generated a number of outputs, among them i) new collaborative
links, ii) new insights, understanding and training into economic aspects of
mental health care, and iii) a large and rich data set on costs and outcomes for a
sampled mentally ill population. On the basis of these outputs, we can conclude
that the conduct of mental health economic analysis in low-income countries is
both feasible and practicable, and we are confident that centres in low-income
countries who possess a basic grounding in research methodology and an interest
in addressing issues of cost-effectiveness will be able to carry out economic
analysis alongside their other activities.
Unmet mental health needs in the community The project reinforced the
findings of previous epidemiological studies that common mental disorders are
indeed common (an estimated 12-18% of the adult populations of the Bangalore
catchment areas, and 28-39% in the Rawalpindi site), and that there exists a
significant pool of unmet mental health need. This study has also been able to
investigate the economic consequence of this identified unmet need at the level of
individuals, families and local health services. For example, it was found that only
just over half of the sampled populations in the Bangalore site had contacted
services at all, and an even smaller proportion (20-30%) were in contact with
government primary health care workers.
The cost of common mental disorders Despite, and to a larger extent
because of, low rates of contact with health care professionals able to detect and
manage psychiatric morbidity, the health care and other patient/family
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mental disorder are considerable (by local standards; there are 65 Indian Rupees
and 80 Pakistani Rupees to £1, but the daily wage of an agricultural worker is
only Rs 50-100 in India, Rs 150 in Pakistan). At baseline assessment, the mean
cost associated with health care were Rs 160-370 per month in the Bangalore site
(of which over 80% was private expenditure), and Rs 550-650 in the Rawalpindi
site (the majority of which was privately incurred). The single largest category of
health care cost was consultations with local private general or traditional
practitioners (neither of whom are qualified or trained to detect or treat
psychiatric morbidity). Thus, whilst individuals are seeking help, and spending
significant amounts of money in the process, they are not in the main receiving
appropriate care for their mental health condition. The imputed costs associated
with reported levels of informal caregiving (mainly by female members of the
individual’s extended family), travelling time/expense and lost days of work are
also very considerable (an estimated Rs 686-851 in the month preceding baseline
assessment in Bangalore, and over Rs 3,500 in Rawalpindi).
Impact of integrating mental health care into primary care Calculation of
the relative cost-effectiveness of the intervention itself, which consisted of
training and supporting primary health care staff in the detection and
management of mental disorders, was not in itself a specific objective of this
study (since such an analysis would require a larger sample, a longer follow-up
period and a more powerful, experimental study design than was possible with
the available time and resources). Our use of an observational, community survey
design in fact complicates evaluation of the impact of an intervention
implemented at the PHC facility level, particularly in settings where only a
modest proportion of the sampled populations are actually in contact with
primary care workers. The outcome results obtained also appear to suggest a
different intervention effect, namely the interaction of subjects with the mental
health professionals who undertook the research interviews. The very act of
interviewing individuals about their mental health state, and the consequent
advice to seek care locally, appears to have had a powerful effect, most notably in
the Lehtrar catchment area (in which no mental health training had been
provided) where high levels of psychiatric morbidity at the baseline assessment
saw very significant improvements over the course of the study.
In terms of changes over time within (rather than between) catchment areas, the
results for both localities in the Bangalore site, and in the Lehtrar locality of the
Rawalpindi site, suggest that alerting members of the local population to their
mental health care needs (and in the case of the integrated care locality in
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Table 1 Summary of changes in cost and outcome over period of study
Bangalore site Rawlpindi site
Jigani Sakalawara Lehtrar Taxila
(Standard care) (Integrated care) (Standard care) (Integrated care)
Costs
Health care costs
Patient and family costs
Total costs
Outcomes
Depression score (HDRS total)
Disability score (BDQ total)
Quality of life (WHOQOL domains)
Lower
Lower
Lower
Improved
Improved
Improved
Higher
Lower
Lower
Improved
Improved
Improved
Higher
Lower
Lower
Improved
Improved
Improved
Higher
Higher
Higher
Improved
Worsened
No change
Figures in bold indicate a statistically significant change.Bangalore, also training primary care workers in mental health care) is not only
associated with clear improvements in the outcome domains of depression,
disability and quality of life, but also reduces the economic burden of mental
disorder (Table 1). By contrast, there are increased costs of care in the integrated
care locality of the Rawalpindi site and no clear benefits in terms of client
outcomes, which suggests that the intervention has had no clear beneficial impact
on the mentally ill population of that area (a plausible reason for this is that there
was a strong preference for, and consequent reliance on, private care providers in
this population).
Future policy priorities and research needs
The most pressing policy priority is to enhance the recognition of common
mental disorders as a public health concern, not only through epidemiological,
clinical, economic and social research, but through the dissemination of that
evidence to decision-makers at all levels of federal and local government.
Increased provision of appropriate care and resources for common and more
severe mental disorders cannot be expected to occur without a corresponding
improvement in the awareness and understanding of key decision-makers. An
important aspect of this awareness-raising campaign, already under way as part of
the Nations for Mental Health initiative, is the reduction of stigma towards
mental illness, both at a policy and public level. Official support and sponsoring
of low-cost, wide-coverage mental health promotion campaigns would constitute
a significant step forward in this regard, as well as being likely to represent a
highly cost-effective use of resources.
Training in the detection and treatability of common mental disorders needs to
be accompanied by the availability of suitable drugs. Whilst the high acquisition
cost of newer anti-depressants is an obvious constraint, conventional tricyclics are
very cheap and equally effective (the newer class of drugs are considered no more
efficacious, but are better tolerated). And yet in many of the pharmacies visited
in the present study, such medication is not stocked or available. The
establishment and implementation of an essential drug list for mental (and
neuropsychiatric) disorders is likely to represent a further policy priority in many
low-income countries.
Finally, whilst the current study has generated data on the service utilisation
patterns and costs of individuals with a diagnosed common mental disorder
among two catchment area populations in India and Pakistan, there remains a
chronic shortage of economic data to support mental health policy or resource
allocation discussions at a national or international level. There is consequently a
need to undertake further studies that not only address the relative
cost-effectiveness of alternative interventions or strategies (using a prospective,
experimental design), but also broaden our understanding of the
inter-relationship between psychiatric morbidity and disability on the one hand,
and access to and uptake of services on the other. Indeed, interventions for
common mental disorders need to be carefully planned in accordance with the
prevailing health-seeking behaviours of the local population(s) as well as other
demographic, cultural and socioeconomic factors, since these factors are likely to
contribute significantly to their overall effectiveness and cost-effectiveness.
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Longitudinal investigation of depression outcomes (LIDO)
This is an international study of the quality of life and economic correlates of recognised major depression in
primary care. Participating countries are Spain, Israel, Russia, Australia, Brazil and USA. The study design is
observational, based on a prospective cohort of patients meeting diagnostic criteria for clinical depression
and recruited in primary care settings.
Aims of the economic dimension of the study
 Compare the extent to which treated and non-treated people with major depression make use of services;
 Measure the economic impact of depression on individuals and health services;
 Explore the associations between service costs, depressive symptoms and quality of life.
For further information, please contact Daniel Chisholm.
Key points
 Mental disorders impose a very heavy clinical, social and economic
burden on societies throughout the developing world, but there is a dearth
of cost and outcome data upon which to base needed investment.
 A cost-outcome study of community mental health care in Bangalore, India
and Rawalpindi, Pakistan has demonstrated the feasibility and importance
of conducting economic analysis in these contexts.
 Increased recognition and awareness of mental disorders as a public
health burden, improved availability of essential psychotropic drugs and
further cost-effectiveness studies are identified as key policy priorities.36 Mental Health Research Review 6, May 1999
Economic evaluation of Quetiapine
This is a multi-centre, international double-blind RCT, funded by Zeneca Pharmaceuticals. It involves
concurrent data collection for a range of clinical, economic and quality of life outcomes for approximately 400
patients across fifteen countries. Clinical trials demonstrate that Quetiapine is an effective atypical
antipsychotic drug for the treatment of patients with schizophrenia and other psychotic disorders. CEMH is
examining the economic consequences of its use.
The study aims to:
 Describe care and treatment patterns.
 Collect unit cost measures for services used in each country
 Conduct a cost-consequences evaluation, examining the costs and multiple outcome consequences of the
treatment of people with chronic or subchronic schizophrenia with Quetiapine compared to haloperidol.
 Re-estimate cost-consequences for a number of individual countries.
 Conduct a multivariate analyses of cost and outcome variations across samples.
For further information, please contact Anita Patel at CEMH.
The EPSILON Study: needs, outcomes and costs of people severely
disabled by schizophrenia in five European countries
This study is funded under the European Union’s BIOMED ‘Concerted Action’ programme to assess the
needs, outcomes and costs of people severely disabled by schizophrenia in five European centres
(Amsterdam, Copenhagen, London, Santander, Verona). The study aims to develop and apply a set of
standardised measures in the following domains of care for people with schizophrenia:
 needs for care (Camberwell Assessment of Need; CAN)
 service utilisation (Client Service Receipt Inventory; CSRI)
 service satisfaction (Verona Service Satisfaction Scale)
 quality of life (Lancashire Quality of Life Profile; LQOLP)
 care-giver burden (Involvement Evaluation Questionnaire; IEQ)
Two main stages of the study
 To standardise, translate and qualitatively validate the above measures
 To administer these instruments to a sample of 50-100 patients in each site, both in order to assess the
psychometric properties of the measures and to provide a data set from which to make intra- and
inter-cultural comparisons of costs and characteristics.
Results will be available late 1999. For further information, please contact Martin Knapp or Daniel Chisholm.A ‘Ready Reckoner’ for estimating staff costs
in the NHS
Ann Netten, Jane Knight, Jane Dennett, Roger Cooley and Adam Slight
The Ready Reckoner project was funded by the Department of Health as part of
the Human Resources and Effectiveness Initiative. The aim of the research was
to develop an approach to estimating health service staff costs in a consistent and
comprehensive way which is appropriate to use when evaluating the cost
consequences of innovative uses of staff resources. One of the main objectives
was to develop a piece of software to provide default estimates for a range of unit
costs for a wide variety of doctors, nurses and professions allied to medicine. The
software allows users to replace the default values with local information where
appropriate.
Context
The NHS workforce is large, highly trained and very costly. The degree to which
this workforce is employed in a cost-effective way clearly has important
implications for what can be produced from such a large-scale operation.
Concerns about how best to use this workforce underlie many innovative ways of
working in the NHS (such as nurses taking over tasks traditionally undertaken by
doctors).
When evaluating the cost-effectiveness of innovative patterns of staff working, it
is essential that all the associated costs are appropriately identified so those
involved in planning for the future can consider the full implications of variations
in skill-mix. It is also important that consistent approaches are used to cost
estimation so that like is compared with like when alternative courses of action
are under consideration.
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Box 1 Health service staff included in the Ready Reckoner
Community care Acute sector Primary care
District nurse
Community psychiatric nurse
Health visitor
Auxiliary nurse
Physiotherapist
Occupational therapist
Speech and language therapist
Day ward manager
Staff nurse, 24-hour ward
Staff nurse, day ward
24-hour ward manager
Auxiliary nurse
Physiotherapist
Dietitian
Speech and language therapist
Radiographer
Occupational therapist
Therapy support worker
Pre-registration house officer
Senior house officer
Registrar
Consultant psychiatrist
Consultant surgeon
Consultant physician
Practice nurse
General practitionerTraining costs
Although the acquisition of skills tends to be rewarded by higher wage rates, the
long-term cost differential between skilled and unskilled labour is not reflected by
differences in pay. At best, pay differentials may reflect the relative scarcity of
particular skills. In the long term we should include the cost of training each type
of staff, as if (for example) nurses take over doctors’ tasks, more nurses and fewer
doctors will need to be trained for such procedures. To incorporate the resource
implications of maintaining a trained and skilled workforce into the costs of care
delivery, therefore, we need to explicitly value the costs of training and education.
The software allows users to incorporate costs of specific courses where
appropriate. Ongoing training is treated as an annual cost, the basis for
estimation depending on the type of professional. A rather more complex
approach has been required for the inclusion of the investment costs of
qualifications. Rather than basing the estimation of investment costs on the
notional sum of what it would cost to train the current workforce to the present
level of qualification, the objective was to get as close as possible to the long run
marginal opportunity cost. The estimated cost is, therefore, what it would cost in
order to train one additional whole time equivalent member of staff, given
current training requirements and costs. This takes into consideration the cost
implications of current training policies.
Default data have been estimated for the national costs of pre-registration
training of a variety of nurses, doctors, and professionals allied to medicine. Post
registration training costs have also been estimated for community nurses and all
doctors.
The components of this investment are:
 the costs of tuition;
 costs or benefits from clinical placement activities; and
 living expenses where no salary is paid during training; or
 replacement costs where staff are taken away from their posts in order to train.
Before discounting to reflect the distribution of these costs over time the
investment costs of pre-registration training are estimated (at 1997/98 costs) as
£36,130 for psychiatric nurses, £197,660 for doctors and £39,740 for
occupational therapists. Estimates have also been made of the costs of
post-registration training of community nurses and doctors (SHOs, registrars,
GPs and consultants) on a similar basis. A nurse is estimated to cost £12,120 in
order to qualify as a community graduate nurse. Before discounting to reflect the
distribution of costs over time, consultants are estimated to cost £98,430 in
post-registration training.
The initial investment costs need to be discounted, to allow for their expected
distribution over time, and annuitised so they can be included in the unit costs of
the professional. The discounting is straightforward, with the first year of training
taken as the base year. Annuitisation, however, requires that we take into account
the expected returns on this initial investment. In the case of human capital this
means we need an estimate of both the number of years that people will be using
the skills acquired through training and the distribution of those years (taking
into consideration issues such as career breaks, part-time working and early
retirement).
On the basis of analyses undertaken of the 1991 census and 1996 Labour Force
Survey, the expected working life of nurses is estimated as between 19 and 22
years, and of doctors as between 26 years and 29 years. Professions allied to
medicine were estimated as working about 24 years in total; see figure 1. The
data were also used to estimate the expected distribution of these working lives.
On the basis of these data a method was developed for allowing for the
38 Mental Health Research Review 6, May 1999distribution of costs and returns on the
investment (in terms of time spent working in
related professional roles) over time.
In absolute terms, the equivalent annual
investment costs of training ranged from
£4,520 for occupational therapists, through
community psychiatric nurses at £5,820, to
£30,170 for consultant psychiatrists. The
impact on unit costs of staff of including
investment costs was examined; see figure 2.
The impact was least on professions allied to
medicine. The lowest impact was for
occupational therapists (16 per cent). The
biggest impact among these professions was
for speech and language therapists where unit
costs are 19 per cent higher
when investment costs of
training are included. For all
types of nurse the impact was
slightly higher, with unit
costs rising by over 20 per
cent when investment costs
are included. The most
marked, and varied, impact
was among doctors. Given
the long-term investment
required for consultants, it
perhaps is not surprising that
the costs including
investment in training are 36
per cent higher than without
this investment cost. But the
most dramatic impact is on
the costs of registrars.
Because a high proportion of
the investment required for a
consultant is required for a
registrar but pay is much
lower, the net effect of including investment costs is to increase unit costs by 60
per cent. If ongoing training costs are included, costs rise by 66 per cent.
For the most part these investment costs are borne by the wider NHS and
individuals undertaking the training rather than trusts, so those costing exercises
that are concerned with narrowly defined costs to the provider organisation
would not want to incorporate these investment costs. The investment costs of
education should always be included, however, when evaluating the
cost-effectiveness of different approaches to using health service staff as it is
important to include all the costs implicit in changing the professional mix.
Evaluations of any innovative working patterns which change the way that staff
are used (such as community psychiatric nurses conducting clinics that may
previously have been staffed by a doctor) should also include the investment cost
of training.
The approach does allow us to make a reasonable estimate of the long-term
investment costs of qualifying health service professionals. Clearly the levels of
investment are such that including annuitised costs is essential if appropriate
conclusions are to be drawn with respect to the cost-effectiveness of changing the
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35%
Figures show increase to hourly cost due to training
Day ward
Note: Percentage increases differ from those in the text as ongoing training is included
in basic cost for comparability across professions.
manager:
G grade
PRHO Physio Practice
nurse
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physician
Professional
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Figure 2 The effect of investment in training on costs of
professionals’ time
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30 29
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Figure 1 Expected working lives (years)patterns of use of professional expertise in the long term. The analysis also shows
that the distribution of returns on investment in education has an important
effect on the estimated equivalent annual cost. This has implications for the
appropriate measurement of costs both when considering innovative staff use and
workforce planning.
Further information
Two volumes describing the findings and methodology of the project have been
published by the PSSRU, together with a CD-Rom containing the PC
compatible computer programme developed. An annual companion volume, Unit
Costs of Health and Social Care, is also produced. Please contact the PSSRU
librarian in Canterbury for ordering details.
40 Mental Health Research Review 6, May 1999
Psychiatric Reprovision in North London
The long-running evaluation of psychiatric reprovision in North London conducted by the Team for the
Assessment of Psychiatric Services (TAPS) completed its findings in the autumn of 1998. During the
thirteen-year research programme, patients from the Friern and Claybury Hospitals were monitored as they
moved to placements in the community, and were followed up one and five years after the index discharge.
The primary focus of the research was the long-stay population, but a number of subsidiary studies
examined other implications of the hospital closure programme.
The Centre for the Economics of Mental Health carried out a full economic evaluation in close association
with the TAPS researchers, and recent findings were reported in each of the earlier editions of the Mental
Health Research Review. A full programme of dissemination is currently in progress. Listed below are some
of the most recent journal articles and book chapters.
Knapp, M.R.J., Hallam, A.J., Beecham, J.K. and Baines, B. (1999) Private, voluntary or public? Comparative cost
effectiveness in community mental health care, Policy and Politics 27, 1, 25-42.
Knapp, M.R.J., Beecham, J.K. and Hallam, A.J. (1997) The mixed economy of psychiatric reprovision, in J. Leff
(ed.) Community Care: Illusion or Reality?, John Wiley & Sons, Chichester, 37-47.
Beecham, J.K., Hallam, A.J., Knapp, M.R.J., Baines, B., Fenyo, A. and Asbury, M. (1997) Costing care in the
hospital and in the community, pp.93-108 in J. Leff (ed.) Community Care: Illusion or Reality?, John Wiley & Sons,
Chichester.
Knapp, M.R.J., Beecham, J.K., Fenyo, A. and Hallam, A.J. (1995) Predicting costs from needs and diagnoses:
community mental health care for former hospital in-patients, British Journal of Psychiatry, 166, 27, 10-18.
Hallam, A.J., Knapp, M.R.J., Beecham, J.K. and Fenyo, A. (1995) Eight years of psychiatric reprovision: an
economic evaluation, pp. 103-124 in M.R.J. Knapp (ed.) The Economic Evaluation of Mental Health Care,
Ashgate, Aldershot.
Key points
 The project developed an approach to estimating health service staff costs in a consistent and
comprehensive way for evaluating the cost consequences of innovative uses of staff resources.
 For such purposes, training and education of staff needs to be explicitly valued, discounted and
annuitised.
 A software programme has been developed which includes default values and allows users to
adapt the information for a range of unit costs.
 National unit costs have been estimated for a wide variety of doctors, nurses and professions
allied to medicine. Including the annual investment costs of training has an important impact on
total values and they should be taken into account whenever there are long-term consequences
for the composition of the workforce.Mental Health Research Review 6, May 1999 41
Some recent CEMH and PSSRU publications
These two pages give brief details of selected recent publications.
CEMH Working Papers and PSSRU Discussion Papers, including those cited in this Review, may be purchased
from Clare Valentine (PSSRU librarian, 01227 827773; C.Valentine@ukc.ac.uk) or Daphne Hargreaves (CEMH,
0171 919 3198; cemh@iop.kcl.ac.uk). They can supply a full list of our mental health research publications,
together with information on charges, which can also be accessed (together with electronic versions of some
publications including this Review) through the PSSRU website: www.ukc.ac.uk/PSSRU/
We aim to disseminate our findings as widely as possible, but both PSSRU and CEMH have to charge for
papers. If a paper is also published as a journal article or book chapter we advise interested readers to obtain
that publication from a library (through the inter-library loan system if necessary) or bookshop.
Issue 11 of the PSSRU Bulletin, which covers the Unit’s work as a whole, is available free of charge. The
PSSRU also publishes a book series under the Ashgate imprint, monographs, and newsletters.
Poverty, disability and the use of long-term care
services
Stephen Almond, Andrew Bebbington, Ken Judge, Roshni
Mangalore and Owen O’Donnell (1999), in Royal
Commission on Long Term Care, A New Era for Older People
Evaluation and the voluntary (nonprofit) sector:
emerging issues
Jeremy Kendall and Martin Knapp (1999), in David Lewis
(ed.) International Perspectives on Voluntary Action,
Earthscan, London
Economic evaluation and conduct disorders
Martin Knapp (1999), in Jonathon Hill and Barbara Maughan
(eds) Conduct Disorders in Childhood, Cambridge University
Press, Cambridge
Needs based planning for community care: a model
for older people
Karin Janzon and Andrew Bebbington (1999), Research
Policy and Planning, 16, 3
Private, voluntary or public? Comparative cost-
effectiveness in community mental health care
Martin Knapp, Angela Hallam, Jennifer Beecham and Barry
Baines (1999), Policy and Politics, 27, 1, 25-41
The cost of antisocial behaviour in younger
children
Martin Knapp, Stephen Scott and Julia Davies (1999),
Clinical Child Psychology and Psychiatry, forthcoming
Assessment approaches for older people receiving
social care: content and coverage
Karen Stewart, David Challis, Iain Carpenter and Edward
Dickinson (1999), International Journal of Geriatric
Psychiatry, 14, September, 147-156
Estimating per unit treatment costs for mental
health and substance abuse programs
Barbara Dickey, Jennifer Beecham, Eric Latimer and Stephen
Leff (1999), The Evaluation Center@HSRI, Cambridge,
Massachusetts
The new drugs for Alzheimer’s disease: are they
cost-effective?
Martin Knapp (1999), Alzheimer’s Disease Newsletter,
forthcoming
Community Care in England and France
Bleddyn Davies, José Luis Fernández and Robin Saunders
(1999), Ashgate, Aldershot
The Cost of Caring: The Economics of Providing
for the Intellectually Disabled
Shane Kavanagh and Lou Opit (1998), Politeia, London
Unit Costs of Health and Social Care 1998
Ann Netten, Jane Dennett and Jane Knight (1998),
PSSRU, Canterbury
A ‘Ready Reckoner’for Staff Costs in the NHS.
Volume I. Estimated Unit Costs
Ann Netten, Jane Knight, Jane Dennett, Roger Cooley
and Adam Slight (1998), PSSRU, Canterbury
A ‘Ready Reckoner’for Staff Costs in the NHS.
Volume II. Methodology
Ann Netten, Jane Knight, Jane Dennett, Roger Cooley
and Adam Slight (1998), PSSRU, Canterbury
Demand for Long-term Care: Projections of
Long-term Care Finance for Elderly People
Raphael Wittenberg, Linda Pickard, Adelina
Comas-Herrera, Bleddyn Davies and Robin Darton
(1998), PSSRU, Canterbury
Economic evaluation and child psychiatric
in-patient services
Jennifer Beecham (1998), pp. 363-373 in Jonathan
Green and Brian Jacobs (eds) Inpatient Child Psychiatry:
Modern Practice, Research and the Future, Routledge,
London.
Extending the limits of care management: an
evaluation of the Lewisham project
Pamela Brown, Richard von Abendorff, David Challis and
John Chesterman (1999), Conference Proceedings:
Dementia Care: can we afford the risk?, Dementia
Services Development Centre, Sydney
The Darlington study: findings and lessons for
care management, health care and community
care
David Challis, Robin Darton and Karen Stewart
(1998), in David Challis, Robin Darton and Karen Stewart
(eds) Community Care, Secondary Health Care and
Care Management, Ashgate, Aldershot, 1998
Linking community care and health care: a new
role for secondary health care services
David Challis, Robin Darton and Karen Stewart
(1998), in David Challis, Robin Darton and Karen Stewart
(eds) Community Care, Secondary Health Care and
Care Management, Ashgate, Aldershot42 Mental Health Research Review 6, May 1999
Is there convergence in the health expenditures of
the EU Member States?
Adelina Comas-Herrera (1998), in E. Mossialos and J. Le
Grand (eds) Health Expenditure in the European Union: Cost
and Control, Ashgate, Aldershot
Shelter with care and the community care reforms
Bleddyn Davies (1998), in R. Jack (ed.) Residential Versus
Community Care: The Role of Institutions in Welfare
Provision, Macmillan, London
Costing community care of people with dementia
Martin Knapp and Rachel Wigglesworth (1998), in Bengt
Winblad, Anders Wimo, Bengt Jonsson and Göran Karlsson
(eds) Health Economics of Dementia, John Wiley & Sons,
Chichester and New York
Cost analysis of the treatment of schizophrenia in
the UK: a comparison of olanzapine and
haloperidol
Steve Almond and Owen O’Donnell (1998),
PharmacoEconomics, 13, 575-588
Health action zones
Linda Bauld and Ken Judge (1998), ESRC Health Variations
Newsletter, 2, July, 10-11
Policy applications of health expectancy
Margaret Bone, Andrew Bebbington and Geraldine Nicolaas
(1998), Journal of Aging and Health, 10, 136-153
Emerging models of care management for older
people and those with mental health problems in
the UK
David Challis, Robin Darton, Jane Hughes, Peter Huxley and
Karen Stewart (1998), Journal of Case Management, 7, 4,
153-160
Economics and ethics in mental health care:
traditions and trade-offs
Daniel Chisholm and Alan Stewart (1998), Journal of Mental
Health Policy and Economics, 1, 55-62
Issues in the design of studies for the economic
evaluation of new atypical antipsychotics: the
ESTO study
Michael Drummond, Martin Knapp, Tom Burns, Keith Miller
and Pamela Shadwell (1998), Journal of Mental Health Policy
and Economics, 1, 1, 15-22
Service support to people in Wales with severe
intellectual disability and the most severe
challenging behaviours: processes, outcomes and
costs
David Felce, Kathy Lowe, Jonathan Perry, Helen Baxter,
Edwin Jones, Angela Hallam and Jennifer Beecham (1998),
Journal of Intellectual Disability Research, 42, 5, 390-408
Economic burden of drug dependency
Andrew Healey, Martin Knapp, Jack Astin, Michael Gossop,
John Marsden, D Stewart, P Lehmann and Christine Godfrey
(1998), British Journal of Psychiatry, 173, 160-165
Income inequality and population health
Ken Judge, Jo-Ann Mulligan and Michaela Benzeval (1998),
Social Science and Medicine, 46, 4-5, 567-579
The impact on general practitioners of the changing
balance of care for elderly people living in
institutions
Shane Kavanagh and Martin Knapp (1998), British Medical
Journal, 317, 322-327
Measuring the economic benefit of treatment
with atypical antipsychotics
Martin Knapp (1998), European Psychiatrist, 13,
supplement 1, 37-45
Public, private and voluntary residential mental
health care: is there a cost difference?
Martin Knapp, Daniel Chisholm, Jack Astin, Paul Lelliott
and Bernard Audini (1998), Journal of Health Services
Research and Policy, 3, 3, July, 141-148
Child care outcomes: economic issues and
perspectives
Martin Knapp and Ana Lowin (1998), Children and
Society, 12, 169-179
Home-based versus hospital-based care for
serious mental illness: controlled
cost-effectiveness study over four years
Martin Knapp, Isaac Marks, Jane Wolstenholme, Jennifer
Beecham, Jack Astin, Bernard Audini, Joe Connolly and
Vik Watts (1998), British Journal of Psychiatry, 172, 6,
506-512
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Martin Knapp, David Wilkinson and Rachel Wigglesworth
(1998), International Journal of Geriatric Psychiatry, 13,
8, 531-543
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Elizabeth Rink, Jane Sims, Rebecca Walker and Linda
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Community, 6, 3, 158-163
Models of specialist employment for people with
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Justine Schneider (1998), Health and Social Care in the
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Choosing an antidepressant: effectiveness
based pharmaco-economics
Alan Stewart (1998), Journal of Affective Disorders, 48,
2-3, 125-133
Cost effectiveness of SSRIs: a European
perspective
Alan Stewart, (1998), Journal of Mental Health Policy
and Economics, 1, 41-49
Needs based planning for community care:
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Andrew Bebbington and Wendy Rickard (1999), PSSRU,
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